Pharmaceutical Implications of Emerging Pathogens : Challenges and Strategies
Pharmaceutical Implications of Emerging Pathogens: Challenges and Strategies in Drug Development The rise of emerging pathogens poses unprecedented challenges to the pharmaceutical industry. These pathogens, which include novel viruses, bacteria, and fungi, threaten drug safety, product quality, and supply chain integrity. Understanding their implications is critical for ensuring regulatory compliance , patient safety, and effective drug development. 🔬 What Are Emerging Pathogens? Emerging pathogens are microorganisms whose incidence in humans or animals has increased in recent decades or threatens to increase in the near future. Examples include: Antibiotic-resistant bacteria: MRSA, Carbapenem-resistant Enterobacteriaceae (CRE) Fungal pathogens: Candida species, Aspergillus species These pathogens can enter pharmaceutical processes through raw materials, personnel, or environmental contamination, potentially compromising sterile and non-sterile products...